The Alzheimer’s Disease (AD) Biomarker Expert Working Group just published a new paper in Neurobiology of Aging. They recommend that certain AD biomarkers be used for clinical assessments, enrolling study participants, and as an outcome in AD clinical trials. Biomarkers, Alzheimer’s, and clinical trials can help find AD faster and can lead to more effective […]
Release of Draft Framework for the National Plan to Address Alzheimer’s Disease
As we committed at the December LEAD meeting, we are circulating the attached draft Framework for the National Alzheimer’s Plan just released by HHS. This is not the draft plan itself, whose release has been delayed by HHS until after the release of the President’s Fiscal Year 2013 budget in early February. This draft Framework […]
America can’t afford to ignore Alzheimer’s
A January 6, 2012 The Des Moines Register op-ed by George Vradenburg and Dr. Andrea McGuire, chairwoman of the board of advisors of the University of Iowa College of Public Health, advocated for increased investment in Alzheimer’s research. According to the article, “One in eight Iowans age 65 and older has it. It is America’s […]
The Path Ahead
A Framework for a Transformative National Plan to Defeat Alzheimer’s Disease The time is now for America to rally the nation behind the challenging but achievable goal of preventing or controlling the disabling symptoms of this disease by 2020 by accelerating development of preventative treatments, focusing federal investments on innovative, outcomes-oriented research, and facilitating high […]